Imaging Diagnostics Premieres CTLM(TM) Human Breast Images At Instrumentarium- Sponsored Medical Conference
FT. LAUDERDALE, Fla., Sept. 2 /PRNewswire/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) announced today that the Company will attend and present the first series of CTLM(TM) human images submitted to the FDA as part of Phase I clinical trials to attendees at the 18th Annual Breast Imaging Conference in Orlando, September 10-12, 1998. The conference is sponsored by Instrumentarium, itself a leader in manufacturing and distribution of medical devices.
The Conference is designed for physicians and allied health professionals. It will review the principals of mammography, breast sonography, breast pathology and cytology presented by a distinguished faculty.
Imaging Diagnostic has developed the world's first patented laser-based imaging device that utilizes of state-the-art-laser technology and sophisticated computed algorithms that create contiguous cross-sectional slice images of the breast. This examination, known as the CTLM(TM), does not require breast compression or x-rays.
SOURCE Imaging Diagnostic Systems, Inc.
CO: Imaging Diagnostic Systems, Inc.; Instrumentarium
ST: Florida |
